How to appeal an Elevance Health pediatric epilepsy denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.

What Elevance Health's policy requires for pediatric epilepsy

Cited policy: BCBS Epilepsy Surgery (Resective / Disconnective / LITT) for Drug-Resistant Pediatric Epilepsy

Drug-resistant epilepsy per ILAE Kwan 2010 (failed >=2 appropriate AEDs at adequate doses). Phase 1 evaluation at level-4 NAEC-accredited epilepsy center: video-EEG with seizures captured, 3T MRI epilepsy protocol, neuropsych, and as indicated PET / SPECT / MEG / fMRI / WADA. Multidisciplinary epilepsy surgery conference recommendation. Procedures covered: focal resection / lesionectomy / temporal lobectomy / hemispherectomy / corpus callosotomy / LITT (laser ablation). Pediatric coverage with developmental urgency.

How Elevance Health denies pediatric epilepsy — and how to counter it

Where Elevance Health pushes back: 1) Surgery too aggressive for a child; 2) Try more medications first; 3) LITT experimental; 4) Hemispherectomy too radical without exhausting other options.

Counter-arguments that hold up: Pediatric Epilepsy Surgery RCT — Dwivedi NEJM 2017 — 77% seizure-free at 12 mo surgery vs 7% medical. AAN/AES 2018 Kanner — refer to comprehensive epilepsy center after 2 AED failures. Engel Class I 60-80% in lesional pediatric candidates. Earlier surgery preserves neurodevelopment + reduces SUDEP risk (Harden AAN/AES 2017 SUDEP guideline). LITT is FDA-cleared (Visualase / NeuroBlate) and standard of care for selected mesial temporal + hypothalamic hamartoma + insular targets — NOT experimental. Hemispherectomy is established standard for catastrophic unihemispheric epilepsy (Rasmussen, hemimegalencephaly, large infarct, Sturge-Weber).

What Elevance Health typically denies for pediatric epilepsy

Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For pediatric epilepsy, expect:

• Step therapy
• Medical necessity for biologics
• Out-of-network for behavioral health
• Bariatric surgery prior auth

Treatments most often denied in this category

These are the pediatric epilepsy treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Epidiolex
• Fintepla
• Diacomit
• Clobazam (Onfi/Sympazan)
• Banzel
• Ztalmy (CDKL5)

How to submit the appeal to Elevance Health

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
3. File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.